Project Grant R01GM160681
Award Date 9/12/25
Completion Date 8/31/29
Dollars Obligated $229K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
- This federal Project Grant award for $353,430, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research into the regulation of ceramide-1-phosphate (C1P) metabolism and its role in cellular metabolic reprogramming. The award aims to investigate how C1P and the enzyme ceramide kinase (CERK) regulate mitochondrial function, lipid droplet biosynthesis, and the induction of ferroptotic cell...
- This Project Grant award of $150,000.00 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports a research project at St. John's University, New York, focused on investigating the role of iron metabolism in regulating ferroptosis, a form of regulated cell death. The key objectives are to: 1) elucidate the molecular mechanisms by which the iron regulatory protein 2 (IRP2) influences ferroptosis...
- This Project Grant award, valued at $453,750.00 and awarded on August 8, 2025, supports research by The General Hospital Corporation (doing business as Massachusetts General Hospital) under the National Institute of General Medical Sciences' (NIGMS) Biomedical Research and Research Training program (CFDA 93.859). The research aims to explore how metabolic pathways control the transition between cell viability, pyroptosis (a lytic cell death program), and apoptosis (non-lytic cell death)....
- This federal Project Grant award of $446,875.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to decipher novel cell death mechanisms and metabolic reprogramming in response to microenvironmental stress. The primary awardee, The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, will leverage their expertise in...
- This federal Project Grant award for $647,301 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to advance the understanding of iron-sulfur enzymes. The key objectives are to: Develop synthetic models of iron-sulfur enzyme active sites to characterize their molecular-level structures and reaction mechanisms, and Improve spectroscopic methods for analyzing the complex iron-sulfur clusters...
- The National Institute of General Medical Sciences (NIGMS), under the federal Biomedical Research and Research Training program (CFDA 93.859), awarded a $412,500 Project Grant to the University of South Florida. The grant supports a research program focused on understanding the molecular mechanisms of cell death and developing small molecule inhibitors to treat diseases associated with dysregulated cell death, including systemic inflammatory response syndrome (SIRS), infection, and heart...
- This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $447,337 to Ball State University to conduct research on the regulator MITONEET and its role in cellular redox homeostasis and signaling. The research aims to investigate how the electronic properties and stability of the MITONEET [2Fe-2S] cluster contribute to the metabolism of sulfur-containing molecules and the...
- This Project Grant award, valued at $559,543.00 and effective from September 5, 2025 to August 31, 2028, is provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The project aims to investigate the overlap between mitotic and ferroptotic pathways using novel hybrid small molecule inhibitors. Key products and services to be delivered include: Characterization of a new class of small molecules capable of...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $397,771 to support research on the mechanisms and consequences of lipid accumulation in necroptosis. The research, conducted by The Research Foundation For The State University Of New York (RF SUNY), will focus on three main areas: identifying lipid modulators of necroptosis, characterizing the acylation of the signaling...
- The federal Project Grant award of $420,000 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to identify the molecular mechanisms of mitochondrial dysfunction in pathological stress conditions. The primary objective is to investigate the processes of oxidative phosphorylation and mitochondrial membrane potential disruption, which can lead to cell death and tissue damage in various diseases....